Seres Therapeutics

Microbiome Report for Week Ending 6/22/19
Microbiome Report for Week Ending 6/22/19
CP Wire
microbiome
Axial Biotherapeutics
EnteroBiotix
Seres Therapeutics
Synlogic
Ginkgo Bioworks
Flag link:
Microbiome Report for Week Ending 6/22/19
microbiome
Axial Biotherapeutics
EnteroBiotix
Seres Therapeutics
Synlogic
Ginkgo Bioworks
Flag link:
Microbiome-Focused Seres Therapeutics Inc. Announces Proposed Common Stock Offering
Microbiome-Focused Seres Therapeutics Inc. Announces Proposed Common Stock Offering
CP Wire
Seres Therapeutics
C. difficile
ulcerative colitis
Flag link:
Microbiome-Focused Seres Therapeutics Inc. Announces Proposed Common Stock Offering
Seres Therapeutics
C. difficile
ulcerative colitis
Flag link:
Microbiome Report for Week Ending 4/6/19
Microbiome Report for Week Ending 4/6/19
CP Wire
C3J Therapeutics
bacteriophage
Enterome
Seres Therapeutics
SER-401
Flag link:
Microbiome Report for Week Ending 4/6/19
C3J Therapeutics
bacteriophage
Enterome
Seres Therapeutics
SER-401
Flag link:
Microbiome Report for Week Ending 3/16/19
Microbiome Report for Week Ending 3/16/19
CP Wire
microbiome
Seres Therapeutics
AstraZeneca
stroke
Flag link:
Microbiome Report for Week Ending 3/16/19
microbiome
Seres Therapeutics
AstraZeneca
stroke
Flag link:
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
Endpoints
AstraZeneca
oncology
microbiome
Seres Therapeutics
Flag link:
Microbiome Report for Week Ending 2/9/19
Microbiome Report for Week Ending 2/9/19
CP Wire
microbiome
Seres Therapeutics
Kallyope
Flag link:
Microbiome Report for Week Ending 2/9/19
microbiome
Seres Therapeutics
Kallyope
Flag link:
New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts
New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts
Fierce Biotech
Seres Therapeutics
layoffs
Flag link:
Microbiome Report for Week Ending 1/19/19
Microbiome Report for Week Ending 1/19/19
CP Wire
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
IPOs
Flag link:
Microbiome Report for Week Ending 1/19/19
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
CP Wire
Seres Therapeutics
microbiome
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics
Flag link:
Microbiome Report for Week Ending 10/6/18
Microbiome Report for Week Ending 10/6/18
CP Wire
Rebiotix
Vedanta Biosciences
Seres Therapeutics
LNC Therapeutics
Synlogic
Flag link:
Microbiome Report for Week Ending 10/6/18
Rebiotix
Vedanta Biosciences
Seres Therapeutics
LNC Therapeutics
Synlogic
Flag link:
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
CP WIre
Seres Therapeutics
microbiome
Flag link:
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
Seres Therapeutics
Flag link:

Pages